Study to compare the effectiveness and safety of two drugs in atopic dermatitis in childre
Phase 3
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2024/02/063274
- Lead Sponsor
- IMS and SUM Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients with severe AD
2. EASI more than 21
3. Objective SCORAD more than 40
4. Chronic relapsing eczema for more than 3months
Exclusion Criteria
1. Patients with deranged liver function test (LFT)
2. Patients with deranged renal function test (RFT)
3. Patients with deranged Complete Blood Counts (CBC)
4. Known case of cardiac disease
5. Known case of hypertension
6. Known case of chronic or recurrent infections
7. Known case / family or contact history of tuberculosis
8. Known case of immunodeficiency syndrome
9. Known case of malignancy
10. Patients with known hypersensitivity to cyclosporine and methotrexate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method